![Dividend Safety Grade](https://s3.amazonaws.com/assets.oxfordclub.com/emails/images/B.jpg) In this week's Safety Net, Chief Income Strategist Marc Lichtenfeld tested the biotech giant on which he once made his best trade. Today, this company is still bubbling with new catalysts, rising free cash flow and a consistent payout record. Discover which biotech is on track for an upgrade in this week's Safety Net. |
No comments:
Post a Comment